Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: Disappearance after rituximab therapy does not predict clinical response

Jie Yang, Qian Tao, Ian W. Flinn, Paul G. Murray, Linda E. Post, Hong Ma, Steven Piantadosi, Michael A. Caligiuri, Richard F. Ambinder

Research output: Contribution to journal › Article › peer-review

159 Scopus citations

Fingerprint

Dive into the research topics of 'Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: Disappearance after rituximab therapy does not predict clinical response'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds